Necrotizing fasciitis in captive juvenile Crocodylus porosus caused by Streptococcus agalactiae: an outbreak and review of the animal and human literature by Bishop, Emma J. et al.
Copyright by the Cambridge University Press 
 
E. J. BISHOP, C. SHILTON, S. BENEDICT, F. KONG, G. L. GILBERT, D. 
GAL, D. GODOY, B. G. SPRATT and B. J. CURRIE (2007). Necrotizing 
fasciitis in captive juvenile Crocodylus porosus caused by 
Streptococcus agalactiae: an outbreak and review of the animal and 
human literature. Epidemiology and Infection, 135, pp 1248-1255. 
doi:10.1017/S0950268807008515. 
 
REVIEW ARTICLE
Necrotizing fasciitis in captive juvenile Crocodylus porosus
caused by Streptococcus agalactiae : an outbreak and review
of the animal and human literature
E. J. BISHOP 1, C. SHILTON 2, S. BENEDICT 2, F. KONG 3, G. L. GILBERT 3,
D. GAL 1, D. GODOY4, B. G. SPRATT 4 AND B. J. CURRIE1*
1 Menzies School of Health Research, Charles Darwin University, Darwin, Northern Territory, Australia
2 Department of Primary Industries, Fisheries and Mines, Darwin, Northern Territory, Australia
3 Centre for Infectious Diseases and Microbiology (CIDM), Institute of Clinical Pathology and Medical Research
(ICPMR), Westmead, NSW 2145, Australia
4 Imperial College London, St Mary’s Medical School, London, UK
(Accepted 22 March 2007; ﬁrst published online 20 April 2007)
SUMMARY
We observed an outbreak of necrotizing fasciitis associated with Streptococcus agalactiae
infection in a group of juvenile saltwater crocodiles (Crocodylus porosus). We undertook
screening of crocodiles and the environment to clarify the source of the outbreak and evaluated
the isolates cultured from post-mortem specimens with molecular methods to assess clonality
and the presence of known group B streptococcal virulence determinants. The isolates were
indistinguishable by pulsed-ﬁeld gel electrophoresis. They were a typical serotype Ia strain with
the Ca-like protein gene, epsilon (or alp1), the mobile genetic elements IS381 ISSag1 and ISSag2,
and belonged to multi-locus sequence type (ST) 23. All of these characteristics suggest they were
probably of human origin. We review the medical and veterinary literature relating to
S. agalactiae necrotizing fasciitis, epidemiology and virulence determinants.
INTRODUCTION
Necrotizing fasciitis is a severe infection involving
the superﬁcial fascia and subcutaneous tissues, which
is associated with early toxin-mediated, systemic
toxicity, and has a described mortality in humans of
30–60% [1, 2]. The underlying pathogenic process
involves the production of destructive enzymes and
toxins by the bacterial organisms that allow evasion
of the host immune defences and the spread of the
bacteria through the tissue planes resulting in rapid
tissue necrosis [3]. The main causal pathogens are
Lanceﬁeld group A streptococci (GAS) and clostridia,
although several other organisms, such as Klebsiella
pneumoniae, Pseudomonas aeruginosa and Vibrio
vulniﬁcus have been described in monomicrobial
infections and polymicrobial necrotizing fasciitis is
also recognized [4]. In 1984, group C and G strepto-
cocci were reported for the ﬁrst time to cause necro-
tizing fasciitis in humans [5].
Streptococcus agalactiae, a group B streptococcus
(GBS) well known for causing pneumonia, meningitis
and sepsis in human neonates [6], has also been re-
ported as a rare cause of monomicrobial necrotizing
fasciitis, both in infants and adults [4, 7–18]. Whilst
S. agalactiae is one of the most important causes
of bovine mastitis and has been isolated from other
animals including dogs, cats, goats, elephants, ﬁsh,
and frogs [19–23], there has previously been only
two reported cases of GBS necrotizing fasciitis in
animals, which occurred in captive bottlenose dol-
phins [24, 25]. The few cases of necrotizing fasciitis
that have been reported in domestic animals have
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mainly involved group G streptococci, with severe
dermal, fascial, and muscular necrosis recognized in
dogs infected with S. canis [26, 27]. Although there
are no speciﬁc reports of S. agalactiae-associated
necrotizing fasciitis in reptiles, GBS septicaemia due
to serotype V has been reported in three subadult,
captive bred, emerald monitors (Varanus prasinus)
which died suddenly, after being fed with contami-
nated mice [28].
Although various virulence mechanisms in GAS
are well characterized, those causing invasive disease
in GBS are not as well understood.
It has been noted that the severe manifestations
of GBS disease resemble GAS infection, and one
author managed to isolate a novel pyrogenic exotoxin
from a patient who died with toxic-shock syndrome
associated with S. agalactiae [29]. Despite common
elements deﬁned with recent genome sequencing of
both organisms [30], there has never been reported
transfer of enterotoxin genes from GAS to GBS.
However, variations in the capsular polysaccharide
antigens, variable surface proteins and numerous
mobile genetic elements are known to contribute to
virulence in GBS [31].
We report a clonal outbreak of necrotizing fasciitis
due to S. agalactiae in a group of juvenile saltwater
crocodiles (Crocodylus porosus) and we describe viru-
lence determinants and the molecular typing proﬁle
of the responsible bacterium. We also review both
the literature of GBS infections in animals and the
potential virulence determinants of GBS.
METHODS
Captive-raised male juvenile crocodiles from several
rearing pens at the Darwin Crocodile Farm, 40 km
south of Darwin in the tropical Northern Territory
of Australia, became unwell over a 3-month period
between November 2005 and January 2006. Aﬀected
animals were aged between 6 and 11 months, were
lethargic and displayed necrotic skin lesions involv-
ing either the ventral body wall or limbs or one
or multiple swollen limbs. The majority of aﬀected
crocodiles either died within a few days or became
moribund and were euthanized for post-mortem
examination. Crocodile farming in the Northern
Territory is intensive, with high stocking densities.
The diet at the time of the outbreak consisted of
kangaroo, horse and buﬀalo meat, supplied frozen
from a local pet meat supplier, with a vitamin/mineral
supplement. The ﬁrst cases occurred following an
inventory count on the farm (stressful to the croco-
diles), and there was a recent history of what were
assumed to be traumatic skin lesions due to ﬁghting
in the aﬀected tanks.
There were 29 deaths recorded during the outbreak
and full post-mortem examinations were performed
on seven animals. Skin, muscle and internal organ
tissues were prepared for histological examination,
Gram stains and bacterial culture. In December 2005,
mouth swabs from ﬁve crocodiles from pens contain-
ing aﬀected animals, water samples from two aﬀected
pens, and two bores and a water heater supplying
the pens were cultured using enrichment media for
streptococcal species. In January 2006, at the end of
the outbreak, ten more mouth swabs were taken for
culture.
Streptococcal isolates from the crocodiles were
observed for haemolysis on tryptone soy agar with
sheep blood and catalase reaction. Lanceﬁeld sero-
grouping was performed with a latex agglutination
test system (Streptococcal Grouping Reagent, Oxoid,
Basingstoke, Hants, UK) and identiﬁcation was
completed with rapid ID 32 Strep (bioMe´rieux,
Marcy l’Etoile, France). Antibiotic susceptibility
testing was performed by agar disc diﬀusion accord-
ing to the method of the Clinical Laboratory
Standards Institute (CLSI).
Macrorestriction analysis of the chromosomal
DNA of isolates was performed using the enzyme
SmaI and subsequent separation of the fragments
by pulsed-ﬁeld gel electrophoresis (PFGE). Chromo-
somal DNA was prepared using a modiﬁcation of
published methods [32, 33]. Slices of DNA-containing
agarose plugs were digested overnight with 20 U
SmaI (New England BioLabs, Genesearch, Arundel,
Queensland, Australia) at 25 xC, then electrophoresed
on a CHEF DRIII system (Bio-Rad Laboratories,
Hercules, CA, USA) for 25 h at 6 V/cm, with ramped
pulse times of 5–40 s in a 1.2% SeaKem Gold agarose
gel (BioWhittaker Molecular Applications, Rock-
land, ME, USA) and 0.5r TBE electrophoresis buﬀer
containing 100 mM thiourea. Lambda DNA con-
catemer PFGE markers (Promega, Madison, WI,
USA) were used as DNA size standards. The gel was
stained with ethidium bromide (0.5 mg/ml, Sigma,
Castle Hill, NSW, Australia) for 45 min, destained in
0.5r TBE for 45 min, and photographed under UV
illumination.
Genotyping was performed, using a GBS molecular
typing system which identiﬁes serotype, protein anti-
gens, mobile genetic elements and seven antibiotic
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resistance genes (including three erythromycin, two
tetracycline and two aminoglycoside resistance genes)
[31, 34, 35]. Three of nine representative S. agalactiae
isolates from three of seven diﬀerent crocodiles were
assessed. Multi-locus sequence typing (MLST) using
the seven house-keeping genes that deﬁne the GBS
MLST scheme was performed on one isolate as pre-
viously described [36], after DNA had been extracted
using the Qiagen DNeasy kit (Qiagen, Doncaster,
Victoria, Australia).
RESULTS
Gross lesions varied from swelling of one or multiple
limbs and/or the ventral or lateral body wall to
sloughing of the skin of these regions to reveal
underlying necrotic subcutaneous tissue and skeletal
muscle (Fig. 1). Histopathological lesions of aﬀected
body wall and limbs generally revealed large regions
of muscle and subcutaneous tissue that had under-
gone coagulation necrosis, classically with wave-like
margins of abundant Gram-positive cocci surrounded
by variable numbers of inﬂammatory cells, includ-
ing phagocytes containing abundant Gram-positive
cocci. Histopathological ﬁndings in other organs were
limited to subtle lesions suggestive of septicaemia,
including mild mixed inﬂammatory cell inﬁltrates
associated with the epicardium and multifocal acute
splenic necrosis. Mixed Gram-negative rods and
Gram-positive cocci were visible in internal organs of
some aﬀected crocodiles.
S. agalactiae was isolated from all seven crocodiles ;
in six from the skin or aﬀected subcutaneous tissue
and in one from the liver. Two additional isolates
were obtained from one crocodile from the lung
and spleen. In addition to S. agalactiae, various
Gram-negative bacteria including Salmonella spp.,
Providencia rettgeri, Pseudomonas aeruginosa and
Edwardsiella tarda were also recovered from internal
organs as well as in some of the body wall and limb
lesions. These were considered secondary invaders.
Streptococcal colonies were b-haemolytic, catalase
negative, grouped to Lanceﬁeld serological group B
and showed the typical biochemical properties of
this species in ID 32 Strep test kits. The culture of one
of ﬁve mouth swabs from live crocodiles taken in
December yielded S. agalactiae. S. agalactiae was not
recovered from any of the ﬁve water samples taken
in December or from ten live crocodile mouth swabs
taken at the end of the outbreak in January. It should
be noted, however, that the mouth swabs and water
samples were taken after a 2-week period of anti-
biotic treatment administered orally in the crocodile’s
food (Sulprim, Ilium Veterinary Products Troy
Laboratories, Smithﬁeld, NSW, Australia).
PFGE of the clinical S. agalactiae isolates demon-
strated that all eight isolates from six of the seven
crocodiles had identical banding patterns (Fig. 2) ; the
ninth isolate from the seventh animal did not resolve
with PFGE. This suggested the cases represented an
outbreak caused by the same strain. Genotyping was
performed on three of nine isolates, from diﬀerent
crocodiles. All isolates demonstrated a genotype
consistent with serotype Ia, with protein alp1 (or,
epsilon) and insertion sequences IS1381, ISSag1 and
ISSag2 ; tetM was the only antibiotic resistance gene
detected. MLST showed that they belonged to ST 23.
The isolates were all susceptible to penicillin, erythro-
mycin, clindamycin, and vancomycin, but resistant
to tetracycline and oxacillin.
Fig. 1. Post-mortem photograph of an aﬀected crocodile,
showing typical lesions of inﬂammation, necrosis and
sloughing of the soft tissue of the ventral neck, thorax and
distal right forelimb (arrow, 10 cm length).
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Fig. 2. Composite photograph of SmaI macrorestriction
pattern of GBS isolates from crocodiles and miscellaneous
human clinical specimens. Lanes 2, 9, 17, phage lambda
DNA ladder; lanes 1, 3–8, 10, 13, isolates of crocodile origin
(lane 6 unresolved) ; lanes 11, 12, 14–16, 18 various human
clinical isolates (kb, kilobases).
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DISCUSSION
GBS are increasingly recognized as virulent human
pathogens and 22 human cases of necrotizing fasciitis
associated with this organism have been reported in
the literature [4, 7–18]. Five of these cases occurred
in children and three of these were infants aged <12
weeks [7–10]. Of note, S. agalactiae necrotizing
fasciitis in adults has a tendency to occur in patients
with diabetes and other comorbidities resulting in
relative immunosuppression, with a high mortality
[12, 18]. The virulence of the organism in these cases
has led authors to postulate that it has ‘GAS-like be-
haviour ’. Although no molecular typing or analysis
of virulence factors was reported on isolates from
any of the human cases, one author described the
puriﬁcation of a novel pyrogenic exotoxin in separate
case of S. agalactiae toxic shock syndrome without
necrotizing fasciitis [29].
The most notable contribution of S. agalactiae to
disease in animals is due to its predilection to colonize
mammary glands of various ruminants, where it can
survive for extended periods, causing clinical and
subclinical mastitis and aﬀecting milk quality [37]. It
is also a major piscine pathogen, causing morbidity
among freshwater, estuarine and marine ﬁshes, such
that a vaccine has been developed and trialled in
this context [38]. In the one previously reported case
of GBS necrotizing fasciitis in animals, from a 15-
year-old female common bottlenose dolphin, the
marine mammal presented with vomiting, renal fail-
ure and liver dysfunction [24]. The only known risk
factor was skin lesions sustained from ﬁghting with a
male. Septicaemia and endotoxic shock, possibly due
to clostridial infection, were suspected and ceftriaxone
and dexamethasone were given. Despite this, the
dolphin died 2 h after the onset of clinical signs.
The cases reported here of necrotizing fasciitis in
C. porosus juveniles represent the ﬁrst clonal outbreak
of S. agalactiae necrotizing fasciitis described in a
reptile. This is notable because both necrotizing
fasciitis and infection with S. agalactiae are very un-
usual in reptiles. This is despite various bacteria often
being identiﬁed in ulcers of crocodiles, subsequent to
bite injuries. However, while Gram-negative bacteria
are common aetiological agents of septicaemia in
juvenile crocodiles, they have generally not been ob-
served to cause lesions of fasciitis. The only potential
suggestion of a possible case of bacterial necrotizing
fasciitis in the reptile literature came from one large
study of skin lesions in crocodiles. A C. porosus
juvenile that died after not eating and being listless
for several days had extensive necrosis of the sub-
cutis with lifting of the entire scales. Extensive
subcutaneous oedema, myolysis and large colonies
of Gram-positive bacteria were seen at necropsy, as
well as organ ﬁndings consistent with fulminating
bacterial septicaemia, but no culture ﬁndings were
given [39]. Moreover, an earlier study from 1993
noted that b-haemolytic streptococci were isolated
from two of nine frozen tail meat samples from
Nile crocodiles (C. niloticus), but identiﬁed these
isolates as S. equisimilis (probably the currently rec-
ognized S. dysgalactiae var. equisimilis [either group C
or G]) [40].
Another major point of interest highlighted by the
cases we have described, is the fact that these cases
occurred when the animals were still aged<1 year. In
the only other reported case of invasive GBS disease
in reptiles, a clonal outbreak of group B septicaemia
in emerald monitors, the animals were also described
as ‘subadult ’, but no further detail was given regard-
ing age [28]. Similar infections in humans have
occurred in both adults and infants, so it is unclear
whether younger age could potentially increase sus-
ceptibility to overwhelming GBS infection in animals.
There may be other factors more important than
age, such as the high stocking densities increasing the
potential for bite wounds and the stress of captivity,
which was also considered a possible predisposing
factor in the reported case of necrotizing fasciitis in a
dolphin [24].
The source of the outbreak reported in emerald
monitors was proven to relate to contamination of
mice used for feeding, when nine of 165 remaining
dead mice had GBS isolated from the gastrointestinal
tract, with an identical banding pattern on PFGE
to that of the infected monitors [28]. In contrast,
although, cutaneous lesions from ﬁghting may have
provided a portal of entry for the organism, the
source of infection in our outbreak remains uncertain.
None of the water samples taken at the time of the
outbreak had positive culture results. Culture of one
of a total of 15 mouth swabs from live crocodiles in
the same pens as aﬀected animals yielded S. agalac-
tiae, suggesting that the organism may inhabit
mucous membranes. The various dietary items fed to
the crocodiles at the time were not cultured, therefore,
the possibility of infection through the feed remains
uninvestigated.
Interestingly, when considering the potential origin
of the GBS, the genotyping results demonstrate a
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proﬁle more consistent with streptococci of human
rather than bovine origin. Bovine isolates are often
non-typable, but of those that are typable a high
proportion belong to serotype III [41]. Unlike isolates
from humans and unlike the strains reported in this
outbreak, bovine isolates are usually susceptible to
tetracycline [19], and only a minority have mobile
genetic elements, including ISSag1 and ISSag2.
When present, such mobile genetic elements probably
encode a pathogenicity-like island which determines
virulence for humans and possibly other animals such
as crocodiles [42]. GBS adhesin genes scpB, and lmb,
coding for C5a peptidase and laminin-binding pro-
tein, respectively, are part of a 16-kb composite
transposon ﬂanked by the ISSag2 insertion sequences
[43]. These two genes are 98% identical with their
counterparts in GAS and all human GBS isolates
examined to date contain them, whereas they are
present in only 20% of animal GBS isolates, sug-
gesting possibly a speciﬁc adaptation to colonization
of the human host [44].
In view of the rarity of necrotizing fasciitis in ani-
mals and indeed, of S. agalactiae as a cause of this
disease in humans, further consideration should be
given to the genotypic characteristics of the aggressive
clone responsible for this outbreak. Of the nine dif-
ferent GBS serotypes, capsular type Ia, although fre-
quently isolated in cases of neonatal sepsis, is not
as signiﬁcantly associated with invasive human neo-
natal disease as is serotype III [45]. However, reported
serotypes causing necrotizing fasciitis in humans
vary from Ib and III, to VI [7, 9, 13]. Similarly, GAS
necrotizing fasciitis has been shown to occur from a
wide diversity of GAS strains and not just the notably
virulent M1 serotype [46, 47]. Interestingly, S. aga-
lactiae of serotype Ia has previously been isolated
from the inner organs of a monkey which died of
sepsis [21]. Whilst capsular polysaccharide has an
important role in allowing the organism to evade
phagocytosis, other virulence factors are important
including haemolysin, C5a peptidase, superoxide dis-
mutase, lipoteichoic acid and laminin-binding pro-
tein. The surface protein antigen epsilon, identiﬁed
in our isolates, is one of a group of variable antigens
that contribute to virulence and elicit protective
immunity [31, 48].
Other factors previously identiﬁed as being in-
volved in the complex virulence mechanisms of GBS
include the CovS/CovR two-component global regu-
latory system, which is involved in regulating the
expression of virulence genes [49]. Sequencing and
comparison of a serotype III and serotype V whole
genome sequence revealed that the genomes were
very similar, with the only major diﬀerence being the
capsulation loci and mobile genetic elements. This
suggested that the capsulation loci or pathogenicity
islands are the main determinants of serotype III
strains in causing invasive disease [50]. Further re-
search has focused on the role of insertion sequences.
The IS1548 insertion sequence in the hylB gene has
been associated with strains identiﬁed from patients
with endocarditis [51], and from neonatal CSF iso-
lates [45], but was not found in either the S. agalactiae
isolates from the emerald monitors with sepsis [28]
or in our isolates from C. porosus. Ia-alp1-IS1381 is
the commonest protein and mobile genetic element
proﬁle of human isolates of serotype Ia and, based on
a limited comparison between our genotyping method
and MLST, is usually associated with ST 23 [52].
IS1381 is found in most serotypes except the hyper-
virulent type III subtype (typically ST 17), and was
present in our isolates [31, 52]. In addition to factors
related to the organism, host factors may aﬀect the
pathogenesis of GBS infection in both humans and
animals. Crocodiles can be expected to have many
of the same components of the immune system as
mammals. Speciﬁcally, they have been shown to have
serum complement activity, with a main diﬀerence in
reptiles being temperature dependence of immune
function. [53].
The MLST type ST 23 identiﬁed in our outbreak
strain of GBS, can be considered in view of the in-
formation it may provide, both in terms of virulence
and the origin of the organism. Prior attempts to de-
ﬁne correlations between S. agalactiae MLST and
virulence have revealed only that ST 17 appears to
be a hypervirulent lineage associated with neonatal
sepsis, in keeping with the reputed aggressive nature
of serotype III [34, 54]. Despite an initial model pos-
tulating an animal origin of the hypervirulent clone
[55], Brochet et al. compared the genome content of
ST 17 (human) and ST 61 (bovine) strains, which
are closely related by MLST and concluded that the
genome of the common ancestor was probably closer
to that of human ST 17 strains than to that of the
ST 61 strains of bovine origin [56]. A prior study
which performed MLST analysis on human and
bovine isolates also examined four disease-causing
isolates from other animals (one elephant, two dogs
and a goat). Three of the 50 strain types found were
present in both human and bovine isolates, whilst
four unique strain types were present in the other
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animals [55]. In our case, a clonal outbreak was
caused by ST 23. MLST shows that isolates with
the same sequence type can have diﬀerent capsular
serotypes. Both serotypes Ia and III have been rep-
resented by ST 23, but the majority are Ia, consist-
ent with our genotype ﬁndings of Ia in this study
[34, 57]. This sequence type has been reported as
one of two major genotypes from cattle [58]. How-
ever, ST 23 was also found to be a common se-
quence type in a collection of human isolates from
maternal carriage and fetal invasive disease [57].
Although found to be a prevalent sequence type
both in the latter study and in MLST analysis of the
global human S. agalactiae [36], there has been no
speciﬁc association demonstrated between this se-
quence type and invasive disease in humans. Another
study found ST 23 to be less commonly represented
among invasive human adult and neonatal iso-
lates of S. agalactiae than ST 17 and ST 19 [59].
Our ﬁndings in this clonal outbreak of necrotizing
fasciitis, suggest that the hypervirulent nature of the
GBS involved may not relate to the sequence type,
and the MLST results do not unequivocally conﬁrm
a human source for the outbreak. However, if this
disease outbreak was indeed from a human source,
it has implications for safe husbandry and handling
of such animals under conditions of intensive
farming.
Current approaches to vaccine development in
humans aim to overcome serotype-speciﬁcity by
targeting vaccine candidates other than capsular
polysaccharide, including C5a peptidase, Sip and the
B-component of the C protein, which have elicited
protective immunity in mice [60]. In ﬁsh, another
species in which the possibility of vaccination against
S. agalactiae is being investigated; a vaccine prepared
by concentrating the extracellular products from
clariﬁed killed S. agalactiae produced a signiﬁcant
degree of protection against experimental infection
[38].
In conclusion, this is the ﬁrst clonal outbreak of
necrotizing fasciitis from S. agalactiae described in a
reptile species. Notably, genetic proﬁling and MLST
suggest this may potentially have been caused by a
strain of human origin, being serotype Ia MLST 23,
with serotype Ia known to be the second most com-
mon invasive serotype in neonates and a capable
pathogen, as demonstrated in this case. Although
necrotizing fasciitis related to S. agalactiae remains a
rare clinical problem in humans and animals, reptile
keepers should be aware of this novel, severe cause
of morbidity and mortality, which potentially has a
predilection for juveniles and occurrence in circum-
stances of intensive husbandry.
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